Regulation of dimethyl-fumarate toxicity by proteasome inhibitors
about
Rationally Repurposing Ruxolitinib (Jakafi (®)) as a Solid Tumor TherapeuticRuxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROSSecond-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis.Repurposing Tecfidera for cancer.Monomethyl fumarate inhibits pain behaviors and amygdala activity in a rat arthritis model.Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis.
P2860
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors
@ast
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors
@en
type
label
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors
@ast
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors
@en
prefLabel
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors
@ast
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors
@en
P2093
P2860
P1476
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors
@en
P2093
Andrew Poklepovic
Jane L Roberts
Laurence Booth
Matthew Peery
Nichola Cruickshanks
Seyedmehrad Tavallai
P2860
P304
P356
10.4161/15384047.2014.967992
P50
P577
2014-01-01T00:00:00Z